SIRT3 and juvenile Huntington disease: ε-Viniferin (2) had an anti-inflammatory effect via the targeting of formyl peptide receptor 1 in human neutrophils [36], and Sirtuin 3 (SIRT3)-mediated neuroprotective effects in Huntington’s disease models and Parkinson’s disease models caused by rotenone administration of SH-SY5Y cells [37].